Revenue | ₹219.16Cr |
Net Profits | ₹44.06Cr |
Net Profit Margins | 20.10% |
Concord Biotech Ltd’s revenue fell -3.65% since last year same period to ₹219.16Cr in the Q1 2025-2026. On a quarterly growth basis, Concord Biotech Ltd has generated -50.11% fall in its revenue since last 3-months.
Concord Biotech Ltd’s net profit fell -26.06% since last year same period to ₹44.06Cr in the Q1 2025-2026. On a quarterly growth basis, Concord Biotech Ltd has generated -68.62% fall in its net profits since last 3-months.
Concord Biotech Ltd’s net profit margin fell -23.26% since last year same period to 20.10% in the Q1 2025-2026. On a quarterly growth basis, Concord Biotech Ltd has generated -37.1% fall in its net profit margins since last 3-months.
The revenue for Concord Biotech Ltd in the Q1 results 2025 was ₹219.16Cr.
The net profit for Concord Biotech Ltd in the Q1 results 2025 was ₹44.06Cr.
The net profit margin for Concord Biotech Ltd in the Q1 results 2025 was 20.10%.
The revenue for Concord Biotech Ltd in the Q1 results 2024 was ₹227.46Cr.
The net profit for Concord Biotech Ltd in the Q1 results 2024 was ₹59.59Cr.
The net profit margin for Concord Biotech Ltd in the Q1 results 2024 was 26.20%.